These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 35385733)

  • 61. [Influencing Factors and Significance of Tumor-associated Macrophage Polarization 
in Tumor Microenvironment].
    Ge W; Wu W
    Zhongguo Fei Ai Za Zhi; 2023 Mar; 26(3):228-237. PubMed ID: 37035885
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Single-cell RNA sequencing reveals intra-tumoral heterogeneity of glioblastoma and a pro-tumor subset of tumor-associated macrophages characterized by EZH2 overexpression.
    Chen X; Chen Y; Chen X; Wei P; Lin Y; Wu Z; Lin Z; Kang D; Ding C
    Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166534. PubMed ID: 36057370
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies.
    Kumari N; Choi SH
    J Exp Clin Cancer Res; 2022 Feb; 41(1):68. PubMed ID: 35183252
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tumor cells induce LAMP2a expression in tumor-associated macrophage for cancer progression.
    Wang R; Liu Y; Liu L; Chen M; Wang X; Yang J; Gong Y; Ding BS; Wei Y; Wei X
    EBioMedicine; 2019 Feb; 40():118-134. PubMed ID: 30711520
    [TBL] [Abstract][Full Text] [Related]  

  • 65. S100A4 enhances protumor macrophage polarization by control of PPAR-γ-dependent induction of fatty acid oxidation.
    Liu S; Zhang H; Li Y; Zhang Y; Bian Y; Zeng Y; Yao X; Wan J; Chen X; Li J; Wang Z; Qin Z
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34145030
    [TBL] [Abstract][Full Text] [Related]  

  • 66. MGP
    Chang K; Jiao Y; Zhang B; Hou L; He X; Wang D; Li D; Li R; Wang Z; Fan P; Zhang J
    Int Immunopharmacol; 2024 Apr; 131():111818. PubMed ID: 38460300
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Macrophages in tumor: An inflammatory perspective.
    Goswami KK; Bose A; Baral R
    Clin Immunol; 2021 Nov; 232():108875. PubMed ID: 34740843
    [TBL] [Abstract][Full Text] [Related]  

  • 68. TREM2
    Tan J; Fan W; Liu T; Zhu B; Liu Y; Wang S; Wu J; Liu J; Zou F; Wei J; Liu L; Zhang X; Zhuang J; Wang Y; Lin H; Huang X; Chen S; Kuang M; Li J
    J Hepatol; 2023 Jul; 79(1):126-140. PubMed ID: 36889359
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy.
    Zhang SY; Song XY; Li Y; Ye LL; Zhou Q; Yang WB
    Pharmacol Res; 2020 Nov; 161():105111. PubMed ID: 33065284
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Functional polarization of tumor-associated macrophages dictated by metabolic reprogramming.
    Zeng W; Li F; Jin S; Ho PC; Liu PS; Xie X
    J Exp Clin Cancer Res; 2023 Sep; 42(1):245. PubMed ID: 37740232
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Siglec-9
    Wang Y; He M; Zhang C; Cao K; Zhang G; Yang M; Huang Y; Jiang W; Liu H
    J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37709296
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immunosuppressive TREM2(+) macrophages are associated with undesirable prognosis and responses to anti-PD-1 immunotherapy in non-small cell lung cancer.
    Zhang H; Liu Z; Wen H; Guo Y; Xu F; Zhu Q; Yuan W; Luo R; Lu C; Liu R; Gu J; Ge D
    Cancer Immunol Immunother; 2022 Oct; 71(10):2511-2522. PubMed ID: 35278107
    [TBL] [Abstract][Full Text] [Related]  

  • 73. BRD4 Inhibition by AZD5153 Promotes Antitumor Immunity via Depolarizing M2 Macrophages.
    Li X; Fu Y; Yang B; Guo E; Wu Y; Huang J; Zhang X; Xiao R; Li K; Wang B; Hu J; Sun C; Chen G
    Front Immunol; 2020; 11():89. PubMed ID: 32184777
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dissecting prostate Cancer: Single-Cell insight into Macrophage Diversity, molecular Prognosticators, and the role of Peptidylprolyl Isomerase F.
    Guan B; Huang C; Meng L; Zhang S; Liu Q; Wang X; Li X; Hao Z
    Int Immunopharmacol; 2024 Sep; 138():112599. PubMed ID: 38959543
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Targeting tumor associated macrophages in hepatocellular carcinoma.
    Xu W; Cheng Y; Guo Y; Yao W; Qian H
    Biochem Pharmacol; 2022 May; 199():114990. PubMed ID: 35288152
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A novel insight into cancer therapy: Lipid metabolism in tumor-associated macrophages.
    Ren Y; Wang M; Yuan H; Wang Z; Yu L
    Int Immunopharmacol; 2024 Jun; 135():112319. PubMed ID: 38801810
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tumour-associated macrophages heterogeneity drives resistance to clinical therapy.
    Guo S; Chen X; Guo C; Wang W
    Expert Rev Mol Med; 2022 Apr; 24():e17. PubMed ID: 35400355
    [TBL] [Abstract][Full Text] [Related]  

  • 78. PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophages.
    Yamaguchi Y; Gibson J; Ou K; Lopez LS; Ng RH; Leggett N; Jonsson VD; Zarif JC; Lee PP; Wang X; Martinez C; Dorff TB; Forman SJ; Priceman SJ
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35738799
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Engineering nanoparticles-enabled tumor-associated macrophages repolarization and phagocytosis restoration for enhanced cancer immunotherapy.
    Gong Y; Gao W; Zhang J; Dong X; Zhu D; Ma G
    J Nanobiotechnology; 2024 Jun; 22(1):341. PubMed ID: 38890636
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Metabolomic profiling of tumor-infiltrating macrophages during tumor growth.
    Umemura N; Sugimoto M; Kitoh Y; Saio M; Sakagami H
    Cancer Immunol Immunother; 2020 Nov; 69(11):2357-2369. PubMed ID: 32518979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.